XML 39 R30.htm IDEA: XBRL DOCUMENT v3.2.0.727
Business and Organization (Details)
$ / shares in Units, $ in Millions
Jun. 03, 2015
USD ($)
$ / shares
May. 05, 2015
USD ($)
$ / shares
shares
Bio-Reference    
Business Acquisition [Line Items]    
Consideration transferred $ 1,300.0  
EirGen Pharma Ltd    
Business Acquisition [Line Items]    
Consideration transferred   $ 133.8
Cash paid at closing date   100.2
Common stock value   $ 33.6
Common Stock    
Business Acquisition [Line Items]    
Stock price | $ / shares   $ 13.88
Common Stock | Bio-Reference    
Business Acquisition [Line Items]    
Conversion ratio on stock 2.75  
Stock price | $ / shares $ 16.74  
Acquired entity share price | $ / shares $ 46.04  
Common Stock | EirGen Pharma Ltd    
Business Acquisition [Line Items]    
Delivery of common stock | shares   2,420,487